Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:ATCCode |
not assigned
|
| gptkbp:CASNumber |
not assigned
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Spero_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
STH-213
|
| gptkbp:indication |
treatment of multidrug-resistant Gram-negative infections
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:status |
investigational drug
|
| gptkbp:bfsParent |
gptkb:Wisconsin_Highway_213
|
| gptkbp:bfsLayer |
7
|